Back to Agenda
Session 1a Focus on New Product Registration
Session Chair(s)
Thean Soo Lo
Regulatory Affairs Management Consultant, TS Consulting, Singapore
Helene Sou, MSc, RAC
Global Regulatory Policy and Innovation, Takeda Pharmaceutical Company Limited., Singapore
Speaker(s)
Hybrid ACCESS/ORBIS Type C Pathway: 1st Industry Experience, Process, Benefits and Considerations
Mi-Young Park
Senior Regulatory Affairs Director, Growth and Emerging Markets, Takeda, Singapore
Edana Loke
Director, JAPAC Regulatory Policy and Intelligence, AbbVie Pte Ltd, Singapore, Singapore
Perspectives on Regulatory Reliance and the TGA Experience
Paul Huleatt, PhD
Indo-Pacific Regulatory Strengthening Program Intl Regulatory Branch, Therapeutic Goods Administration (TGA), Singapore
Accelerating and Streamlining Regulatory Processes
Yuriko Takemura
Coordinator, Division of Asia II, Office of International Programs, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yee Hoo Looi, PhD
Deputy Director, Therapeutic Products Branch, HSA, Singapore
Have an account?